Literature DB >> 33430425

mRNA and miRNA Expression Analyses of the MYC/E2F/miR-17-92 Network in the Most Common Pediatric Brain Tumors.

Renata Gruszka1,2, Krzysztof Zakrzewski3, Paweł Piotr Liberski1, Magdalena Zakrzewska1.   

Abstract

Numerous molecular factors disrupt the correctness of the cell cycle process leading to the development of cancer due to increased cell proliferation. Among known causative factors of such process is abnormal gene expression. Nowadays in the light of current knowledge such alterations are frequently considered in the context of mRNA-miRNA correlation. One of the molecular factors with potential value in tumorigenesis is the feedback loop between MYC and E2F genes in which miR-17-5p and miR-20a from the miR-17-92 cluster are involved. The current literature shows that overexpression of the members of the OncomiR-1 are involved in the development of many solid tumors. In the present work, we investigated the expression of components of the MYC/E2F/miR-17-92 network and their closely related elements including members of MYC and E2F families and miRNAs from two paralogs of miR-17-92: miR-106b-25 and miR-106a-363, in the most common brain tumors of childhood, pilocytic astrocytoma (PA), WHO grade 1; ependymoma (EP), WHO grade 2; and medulloblastoma (MB), WHO grade 4. We showed that the highest gene expression was observed in the MYC family for MYCN and in the E2F family for E2F2. Positive correlation was observed between the gene expression and tumor grade and type, with the highest expression being noted for medulloblastomas, followed by ependymomas, and the lowest for pilocytic astrocytomas. Most members of miR-17-92, miR-106a-363 and miR-106b-25 clusters were upregulated and the highest expression was noted for miR-18a and miR-18b. The rest of the miRNAs, including miR-19a, miR-92a, miR-106a, miR-93, or miR-25 also showed high values. miR-17-5p, miR-20a obtained a high level of expression in medulloblastomas and ependymomas, while close to the control in the pilocytic astrocytoma samples. miRNA expression also depended on tumor grade and histology.

Entities:  

Keywords:  OncomiR-1; brain tumor; ependymoma; medulloblastoma; miR-106a-363; miR-106b-25; miR-17-92; microRNA; pilocytic astrocytoma

Mesh:

Substances:

Year:  2021        PMID: 33430425      PMCID: PMC7827072          DOI: 10.3390/ijms22020543

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  64 in total

Review 1.  Genetic and molecular alterations across medulloblastoma subgroups.

Authors:  Patryk Skowron; Vijay Ramaswamy; Michael D Taylor
Journal:  J Mol Med (Berl)       Date:  2015-09-09       Impact factor: 4.599

2.  Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors.

Authors:  Keith Woods; J Michael Thomson; Scott M Hammond
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

3.  Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis.

Authors:  Yajaira Suárez; Carlos Fernández-Hernando; Jun Yu; Scott A Gerber; Kenneth D Harrison; Jordan S Pober; M Luisa Iruela-Arispe; Matthias Merkenschlager; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

Review 4.  MicroRNAs in cancer: biomarkers, functions and therapy.

Authors:  Josie Hayes; Pier Paolo Peruzzi; Sean Lawler
Journal:  Trends Mol Med       Date:  2014-07-12       Impact factor: 11.951

5.  MicroRNA-20a Regulates Glioma Cell Proliferation, Invasion, and Apoptosis by Targeting CUGBP Elav-Like Family Member 2.

Authors:  Chuangxin Liao; Wenli Chen; Jinshan Wang
Journal:  World Neurosurg       Date:  2018-09-28       Impact factor: 2.104

6.  MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

Authors:  Guang Yang; Ruyou Zhang; Xiaofeng Chen; Yulong Mu; Jing Ai; Chen Shi; Yaohua Liu; Changbin Shi; Lihua Sun; Nikolai G Rainov; Hulun Li; Baofeng Yang; Shiguang Zhao
Journal:  J Mol Med (Berl)       Date:  2011-06-09       Impact factor: 4.599

7.  miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130.

Authors:  Qiang Wang; Yan Chun Li; Jinhua Wang; Juan Kong; Yuchen Qi; Richard J Quigg; Xinmin Li
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

8.  Germline deletion of the miR-17∼92 cluster causes skeletal and growth defects in humans.

Authors:  Loïc de Pontual; Evelyn Yao; Patrick Callier; Laurence Faivre; Valérie Drouin; Sandra Cariou; Arie Van Haeringen; David Geneviève; Alice Goldenberg; Myriam Oufadem; Sylvie Manouvrier; Arnold Munnich; Joana Alves Vidigal; Michel Vekemans; Stanislas Lyonnet; Alexandra Henrion-Caude; Andrea Ventura; Jeanne Amiel
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

Review 9.  The broken cycle: E2F dysfunction in cancer.

Authors:  Lindsey N Kent; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2019-06       Impact factor: 60.716

Review 10.  Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer.

Authors:  Xinju Zhang; Yanli Li; Pengfei Qi; Zhongliang Ma
Journal:  Int J Med Sci       Date:  2018-09-07       Impact factor: 3.738

View more
  2 in total

Review 1.  Context-Dependent Regulation of Gene Expression by Non-Canonical Small RNAs.

Authors:  Kinga Plawgo; Katarzyna Dorota Raczynska
Journal:  Noncoding RNA       Date:  2022-04-29

Review 2.  Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups.

Authors:  Emilia Bevacqua; Jasmin Farshchi; Maria Victoria Niklison-Chirou; Paola Tucci
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.